相似文献
1
The use of a natural history data base to compare outcome among several trials of adjuvant chemotherapy for stage II breast cancer.
Recent Results Cancer Res. 1984;96:148-54. doi: 10.1007/978-3-642-82357-2_18.
2
Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
Recent Results Cancer Res. 1984;96:166-74. doi: 10.1007/978-3-642-82357-2_20.
3
Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
J Clin Oncol. 1985 Feb;3(2):140-3. doi: 10.1200/JCO.1985.3.2.140.
4
Current results of the University of Arizona Adjuvant Breast Cancer trials (1974-1984).
Recent Results Cancer Res. 1984;96:133-40. doi: 10.1007/978-3-642-82357-2_16.
5
Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results.
Recent Results Cancer Res. 1984;96:178-83. doi: 10.1007/978-3-642-82357-2_22.
6
A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
Recent Results Cancer Res. 1984;96:74-89. doi: 10.1007/978-3-642-82357-2_10.
7
Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base.
Am J Clin Oncol. 1987 Oct;10(5):387-95. doi: 10.1097/00000421-198710000-00005.
8
Combination chemotherapy of breast cancer.
Mt Sinai J Med. 1985 Jun;52(6):443-6.
9
Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
Recent Results Cancer Res. 1984;96:155-65. doi: 10.1007/978-3-642-82357-2_19.
10
Adjuvant therapy in primary breast cancer.
Surg Clin North Am. 1985 Feb;65(1):161-80. doi: 10.1016/s0039-6109(16)43540-1.
Zotero 插件